PROCEPT BioRobotics (PRCT) Cash from Financing Activities (2020 - 2026)

PROCEPT BioRobotics (PRCT) has 7 years of Cash from Financing Activities data on file, last reported at $222000.0 in Q1 2026.

• On a quarterly basis, Cash from Financing Activities fell 82.9% year-over-year to $222000.0 in Q1 2026; TTM through Mar 2026 was $10.1 million, a 94.34% decrease from a year earlier, with the FY2025 full-year figure at $11.2 million, down 93.79% from the prior year.
• Cash from Financing Activities for Q1 2026 stood at $222000.0, down from $4.4 million in the prior quarter.
• Over the last five years, Cash from Financing Activities for PRCT reached as high as $170.5 million in Q4 2024 and fell as low as -$1.3 million in Q4 2022.
• Historically, Cash from Financing Activities has averaged $21.3 million across 5 years, with a median of $2.4 million in 2023.
• Across the five-year window, Cash from Financing Activities sank 304.66% in 2022 and surged 20764.74% in 2023, its largest moves.
• Year by year, Cash from Financing Activities stood at -$1.3 million in 2022, then soared by 317.45% to $2.9 million in 2023, then surged by 5850.03% to $170.5 million in 2024, then sank by 97.4% to $4.4 million in 2025, then tumbled by 95.0% to $222000.0 in 2026.
• Per Business Quant data, the three most recent Cash from Financing Activities figures were $222000.0 in Q1 2026, $4.4 million in Q4 2025, and $1.1 million in Q3 2025.